Press Releases

Roche announced that the US FDA has approved Tecentriq® (atezolizumab) as a first-line (initial) treatment for adults with metastatic non-small cell lung cancer (NSCLC) whose tumours have high PD-L1 expression (PD-L1 stained ≥ 50% of tumour cells or...

Covis Pharma announced the initiation of a phase 3 clinical study to assess the safety and efficacy of its asthma drug Alvesco (ciclesonide) in non-hospitalized patients 12 years of age and older with symptomatic COVID-19. Patient recruitment for the...

UPS announced a collaboration with Dr. Reddy’s Laboratories to get 30 tons of pharmaceuticals from India to the United States via Europe. The sensitive cargo had to be shipped within a controlled temperature range to ensure product stability. Given...

Leinco Technologies announced an agreement with Vanderbilt University Medical Center (VUMC) to scale up production of its most promising antibodies for development of a rapid, point of care COVID-19 diagnostic test. Under the agreement, Leinco Technologies will co-develop a rapid,...

Kindred Biosciences, Inc., a biopharmaceutical company developing novel biologics, announced it has entered into an agreement with Vaxart, Inc. for the manufacture of Vaxart's oral vaccine candidate for COVID-19. "We are proud to be contributing toward the effort to develop...

DHL Global Forwarding, Deutsche Post DHL Group’s air and ocean freight specialist, has launched myDHLi, the only fully integrated online platform for freight forwarding customers. myDHLi’s highly intuitive user interface makes it easy to use and ensures that customers...

WuXi Biologics, a global company with leading open-access biologics technology platforms, and the Worcester Business Development Corporation (WBDC) announced the successful signing of a land deal for WuXi Biologics’ clinical and commercial manufacturing facility (MFG11) in Worcester at The...